| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002102842A8 Immunogenic helicobacter surface proteins and their use |
| 04/22/2004 | WO2002098362A3 Use of rank antagonists to treat cancer |
| 04/22/2004 | WO2002094852A8 Taci-immunoglobulin fusion proteins |
| 04/22/2004 | WO2002092784A3 POLYNUCLEOTIDES AND POLYPEPTIDES RELATING TO THE MODULATION OF SIRP α-CD47 |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002081516A8 Narc10 and narc16, programmed cell death-associated molecules and uses thereof |
| 04/22/2004 | WO2002074906A3 Lp mammalian proteins; related reagents |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO2002063009A8 Lp mammalian proteins; related reagents |
| 04/22/2004 | WO2002059268A9 Factor ixa: factor viiia interaction and methods therefor |
| 04/22/2004 | WO2002022803A9 Peptide epitopes recognized by antigen specific cd4+ t lymphocytes |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | WO1990013281A3 Method of suppressing hiv infection |
| 04/22/2004 | US20040078852 DNA encoding a binding protein of an ap2 domain amino acid sequence; enhancing the drought and cold tolerance of recombinant plants |
| 04/22/2004 | US20040078851 Production of human growth factors in monocot seeds |
| 04/22/2004 | US20040078849 Modulating developmental transitions in plants |
| 04/22/2004 | US20040078842 Protein with endo-chitinase activity |
| 04/22/2004 | US20040078841 Root specific promoters |
| 04/22/2004 | US20040078837 Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12 |
| 04/22/2004 | US20040078835 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/22/2004 | US20040078834 Transgenic animal whose genome has a transcriptional regulatory sequence capable of directing expression to b-cells linked to a dna sequence encoding t-cell leukemias |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040078148 Site-directed mutagenesis; green fluorescent proteins; fusion proteins |
| 04/22/2004 | US20040077847 Nucleic acid encoding a pneumoccocal surface protein c gene or epitope |
| 04/22/2004 | US20040077843 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077838 Methods to inhibit the formation of colouring components and to reduce the presence of materials tending to form colouring components to obtain a lighter and less yellow canola protein isolate |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077836 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 04/22/2004 | US20040077835 For treatment of disorders involving the naturally occurring chemokine such as HIV and AIDS related disorders, asthma, allergic rhinitis, atopic dermatitis, atherosclerosis, organ transplant rejection, and rheumatoid arthritis |
| 04/22/2004 | US20040077834 Determining whether a mammal has a disorder associated with the presence of drug-resistant cells having increased DRT111 expression (e.g. drug-resistant cancer), and administering to the mammal a compound that reduces the expression of DRT111 |
| 04/22/2004 | US20040077833 Regulation of human mrp5-like protein |
| 04/22/2004 | US20040077832 Jfy1protein induces rapid apoptosis |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077826 Randomly generated glycopeptide combinatorial libraries |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
| 04/22/2004 | US20040077573 Suppresses overexpression; reducing side effects; such as preventing occurance of plethora while treating anemia with erythropoietin |
| 04/22/2004 | US20040077548 NY-ESO-1 peptide derivatives, and uses thereof |
| 04/22/2004 | US20040077547 Preventing catalytic conversion of factors X, VII AND IX to Xa, VIIa and IXa respectively |
| 04/22/2004 | US20040077546 Osteogenic proteins |
| 04/22/2004 | US20040077545 Synthetic peptide for neurological disorders |
| 04/22/2004 | US20040077542 Apoptotic compounds |
| 04/22/2004 | US20040077541 Methods of using non-human animal Apolipoprotein A-I protein |
| 04/22/2004 | US20040077540 Permeabilizing peptide; reversibly enhancing paracellular transport; inhibits homotypic binding |
| 04/22/2004 | US20040077538 Activates patients own factor VII to VIIa; limits thrombin formation |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077534 Methods and compositions for the treatment and prevention of Staphylococcus a ureus infections |
| 04/22/2004 | US20040077531 Regulating luteotropic hormone secretion; amino acid sequence 35 |
| 04/22/2004 | US20040077528 Entrapping active agent in fumaryl diketopiperazine derivative and solvent washing out impurities; purified insulin for pulmonary administration |
| 04/22/2004 | US20040077526 SR-BI antagonist and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 04/22/2004 | US20040077522 Machine readable media embedded with three dimensional atomic coordinates; drug design |
| 04/22/2004 | US20040077078 Novel human membrane proteins |
| 04/22/2004 | US20040077069 Method for the production of a heterologous protein by a fungus |
| 04/22/2004 | US20040077067 Therapeutic and prophylactic agents derived from aeromonas hydrophila bacterial surface proteins |
| 04/22/2004 | US20040077066 Purified active HCV NS2/3 protease |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040077054 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormal placental |
| 04/22/2004 | US20040077053 Methods to identify growth differentiation factor (GDF) receptors |
| 04/22/2004 | US20040077052 Human cytokine receptor |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077050 Heliothis glutamate receptor |
| 04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 04/22/2004 | US20040077043 Novel dendritic cell wall membrane and use thereof |
| 04/22/2004 | US20040077042 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 04/22/2004 | US20040077041 Gene products for preventing, ameliorating, correcting dysfunctions or diseases including obesity and diseases related to obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorders, |
| 04/22/2004 | US20040077029 Human protooncogene and protein encoded therein |
| 04/22/2004 | US20040077022 Modified peptides as therapeutic agents |
| 04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
| 04/22/2004 | US20040077013 DNA constructs, host cells and production methods for the expression and recovery of polypeptides altered to have glycosylation sites added or deleted; employ a DNA segment corresponding to a mammalian tissue plasminogen activator |
| 04/22/2004 | US20040077011 Novel human gene relating to respiratory diseases and obesity |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 04/22/2004 | US20040076995 Finding that the Nurr1 transciption factor, which forms a heterodimer with the retinoid X receptor, can be mutated in the I box region such that dimerisation does not occur while Nurr1 transcriptional activation activity is retained |
| 04/22/2004 | US20040076992 Novel cell adhesion molecule specific to activated leukocyte |
| 04/22/2004 | US20040076991 Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity |
| 04/22/2004 | US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis |
| 04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
| 04/22/2004 | US20040076981 Fungal gene cluster associated with pathogenesis |
| 04/22/2004 | US20040076976 Aopb gene, protein,homologs, fragments and variants thereof, and their use for cell surface display |
| 04/22/2004 | US20040076970 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 04/22/2004 | US20040076967 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/22/2004 | US20040076965 MIA-2 protein |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/22/2004 | US20040076951 Also antibodies, gene chips, transgenic non-human animals |
| 04/22/2004 | US20040076949 Methods for identifying inhibitors of helicase activity from hepatitis C virus |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076645 Ghrelin-carrier conjugates |
| 04/22/2004 | US20040076643 HIV-encoded chemoattractant |
| 04/22/2004 | US20040076640 Incubating first means expressing the target receptor of an infectious pathogen, with a second means expressing a region regconizing the targets, to form a complex and contacting with a binding agent at different intervals |
| 04/22/2004 | US20040076638 Methods for preparing bacillus anthracis protective antigen for use in vaccines |
| 04/22/2004 | US20040076637 A synthetic peptide comprising an amino acid sequence from the viral glycoprotein 41, a hydrophobic domain, for preventing HIV fusion to a target cell |
| 04/22/2004 | US20040076636 HIV immunogenic complexes |
| 04/22/2004 | US20040076635 Genetic vaccine, polypeptide encoded by a nucleotide sequence genome, a vector, a transgenic cell, for preventing and treating viral infections |